Methotrexate in sarcoidosis: hematologic and hepatic toxicity encountered in a large cohort over a six year period

BACKGROUND: Methotrexate (MTX) is a second line agent for treatment of sarcoidosis. Its long term safety and efficacy in sarcoidosis remains unclear. METHODS: This was a retrospective review of patients seen at the University of Cincinnati Sarcoidosis Clinic over a six year period. For each visit, c...

Descripción completa

Detalles Bibliográficos
Autores principales: Baughman, Robert P., Cremers, Johanna P., Harmon, Martina, Lower, Elyse E., Drent, Marjolein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2020
Materias:
Original Article: Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690061/
https://www.ncbi.nlm.nih.gov/pubmed/33264378
http://dx.doi.org/10.36141/svdld.v37i3.9362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690061/
https://www.ncbi.nlm.nih.gov/pubmed/33264378
http://dx.doi.org/10.36141/svdld.v37i3.9362

Ejemplares similares